Tauriga Sciences
Tauriga Sciences Inc. Products Offerings Now Available on Amazon Prime
Tauriga Sciences Inc. Completes Funding of the Study Protocol Phase of its Recently Initiated Clinical Trial
Tauriga Sciences Inc. Successfully Renews its Status as a U.S. Federal Government Vendor
Tauriga Sciences Inc. Fully Repays its $135,000 Inventory Factoring Credit Facility, Entered Into on October 6, 2020
Tauriga Sciences, Inc. Initiates Clinical Trial to Examine the Effects of Cannabidiol Doses on Pregnant Women with Diagnosis of Hyperemesis Gravidarum
Tauriga Sciences, Inc. to Operate Corporate Exhibitor Table at The Hampton Cannabis EXPO 2021
Tauriga Sciences, Inc. Publishes Positive Mid-Quarter Update for its 2nd Fiscal Quarter 2022 (Period: July 1st – September 30th, 2021)
Tauriga Sciences Inc. Reveals its Upcoming In-Person Tradeshow Schedule: White Label World Expo, MJBizCon, and Kosherfest 2021
